Journal article
The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial
Abstract
BackgroundHomocysteine has been postulated as a novel, potentially reversible risk factor for osteoporosis and related fractures. We evaluated whether homocysteine-lowering therapy with B-vitamins in patients with symptomatic cerebrovascular disease reduced the incidence of osteoporotic fractures.MethodsVITAmins To Prevent Stroke (VITATOPS) was a prospective randomised double-blind placebo-controlled trial in which 8,164 patients with recent …
Authors
Gommans J; Yi Q; Eikelboom JW; Hankey GJ; Chen C; Rodgers H
Journal
BMC Geriatrics, Vol. 13, No. 1,
Publisher
Springer Nature
Publication Date
12 2013
DOI
10.1186/1471-2318-13-88
ISSN
1471-2318